Mark mac Naughton

Mark Mac Naughton is an experienced operations leader with a strong background in the pharmaceutical and manufacturing sectors. Currently serving as the Chief Operations Officer at The Biovac Institute since January 2019, Mark oversees the sterile vaccine manufacturing facility in Cape Town, managing operations, supply chain, projects, and research and development. Prior to this role, Mark worked at Aspen Pharmacare, where responsibilities included strategic project management for a $250 million small molecule sterile manufacturing facility and general management of small volume parenterals operations. Mark’s career began at Tongaat Hulett, where extensive roles in production and engineering spanned over 13 years. Academic credentials include a Master’s in Business Leadership from the University of South Africa and a Higher National Diploma in Chemical Engineering from the University of KwaZulu-Natal.